1. Home
  2. CAVA vs ARWR Comparison

CAVA vs ARWR Comparison

Compare CAVA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$51.87

Market Cap

10.6B

ML Signal

HOLD

Logo Arrowhead Pharmaceuticals Inc.

ARWR

Arrowhead Pharmaceuticals Inc.

HOLD

Current Price

$65.83

Market Cap

12.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
ARWR
Founded
2006
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
12.4B
IPO Year
2023
2009

Fundamental Metrics

Financial Performance
Metric
CAVA
ARWR
Price
$51.87
$65.83
Analyst Decision
Buy
Strong Buy
Analyst Count
23
10
Target Price
★ $91.00
$83.40
AVG Volume (30 Days)
★ 3.2M
1.9M
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 99.80
EPS
★ 0.39
N/A
Revenue
★ $1,179,664,000.00
$16,142,321.00
Revenue This Year
$25.71
N/A
Revenue Next Year
$20.57
N/A
P/E Ratio
$137.21
★ N/A
Revenue Growth
★ 22.41
N/A
52 Week Low
$43.41
$33.02
52 Week High
$98.79
$95.49

Technical Indicators

Market Signals
Indicator
CAVA
ARWR
Relative Strength Index (RSI) 33.86 31.16
Support Level $49.68 $61.25
Resistance Level $74.08 $66.37
Average True Range (ATR) 2.21 4.29
MACD 0.09 -1.17
Stochastic Oscillator 19.49 6.65

Price Performance

Historical Comparison
CAVA
ARWR

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Share on Social Networks: